AzTrials
AzTrials

Test AnxietyNCT07924904

Mindfulness Meditation to Reduce Cognitive Load

A study testing Guided Mindfulness Meditation and Neutral Story Listening in people with Test Anxiety and Stress, Psychological, run by University of South Carolina at 4 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Older adults from disadvantaged backgrounds may score lower on memory and thinking tests because of test anxiety and stress, not because of true memory problems. This can lead to being wrongly diagnosed with dementia. Read more about this study

Who is it for?
Ages 50 years and olderHealthy volunteers can take part
What is being tested?
Guided Mindfulness Meditation and Neutral Story Listening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
4 sitesUnited States
Study dates
14 Nov 2026to 15 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 50 years or older
  • Self-identified low educational attainment (high school diploma or less)
  • Low socioeconomic status per local criteria
  • Able to provide informed consent

Who cannot join

  • Diagnosis of dementia
  • Uncorrected hearing impairment preventing completion of the audio-guided intervention
  • Uncorrected vision impairment preventing completion of the Montreal Cognitive Assessment (MoCA)
  • Current regular mindfulness meditation practice
  • Diagnosis of atrial fibrillation

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Mina Karami, PhD Student contact

18032614523

karamim@email.sc.edu

United States4 sites
  • Lourie Center, Senior Resources, Inc.

    Columbia, South Carolina, 29201

    Mekia A Burgess, 803-252-7734, mburgess@seniorresourcesinc.org

  • University of South Carolina, Aging Gracefully Lab

    Columbia, South Carolina, 29201

    Mina Karami, 8032614523, karamim@email.sc.edu

  • Vital Aging of Williamsburg County, Inc

    Kingstree, South Carolina, 29556

    Robert Welch, 843-354-5496, rwelch@vitalaginginc.org

  • Brookland-Lakeview Empowerment Center

    West Columbia, South Carolina, 29169

    Cindye Richburg Cotton, Ed.D., MBA, 803-744-7943, crichburgcotton@brookland.cc

Other trials in United States

About this study

Official title: Mindful Meditation to Reduce Stress and Cognitive Load for Older Adults

Older adults from disadvantaged backgrounds may score lower on memory and thinking tests because of test anxiety and stress, not because of true memory problems. This can lead to being wrongly diagnosed with dementia. This study will test whether a short, 15-minute guided meditation before taking a memory and thinking test helps older adults do better on the test and feel less stressed. About 60 adults age 50 and older, with lower education and income levels, will take part. Participants will be randomly assigned to either listen to a guided meditation or listen to a neutral story for 15 minutes before taking the test. The study will measure stress using heart rate, blood pressure, saliva samples, and a stress questionnaire.

Read the detailed description

This pilot study examines whether a brief mindfulness meditation intervention, administered immediately before cognitive testing, can reduce measurement bias caused by test-related anxiety in older adults from low-income, low-education backgrounds. Participants are randomized to a 15-minute guided mindfulness meditation session or a 15-minute neutral story-listening control session, both administered immediately before the Montreal Cognitive Assessment (MoCA). Physiological stress markers (heart rate variability, blood pressure, salivary pH) and self-reported anxiety (State-Trait Anxiety Inventory) are assessed to evaluate the intervention's effect on stress. Assessments and physiological data collection are administered via a custom application developed by the study team, which standardizes test administration and scoring.

Being tested
Guided Mindfulness Meditation, Neutral Story Listening
Keywords
mindfulness meditation, MOCA, older adults, health disparities, test anxiety, heart rate variability
Medical subject headings
Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guided Mindfulness MeditationBehavioural

    A 15-minute audio-guided mindfulness meditation session delivered via the study application, administered immediately before cognitive testing.

  • Neutral Story ListeningBehavioural

    A 15-minute audio recording of a neutral, non-mindfulness-based story delivered via the study application, administered once immediately before cognitive testing.

Study groups in NCT07924904
Study groupRoleWhat they receive
Mindfulness MeditationExperimentalParticipants complete a 15-minute guided mindfulness meditation session immediately before completing the Montreal Cognitive Assessment (MoCA).
Receives: Behavioral: Guided Mindfulness Meditation
Story-Listening ControlActive comparatorParticipants listen to a 15-minute neutral, non-mindfulness story immediately before completing the Montreal Cognitive Assessment (MoCA).
Receives: Behavioral: Neutral Story Listening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in MoCA Total Score

    Cognitive performance measured using the Montreal Cognitive Assessment (MoCA), ranging from 0 to 30, with higher scores indicating better cognitive performance, administered by an examiner immediately after the assigned 15-minute intervention session.

    Measured: Immediately following the 15-minute intervention session (single study visit)

Secondary outcomes (10)
  1. Change in Heart Rate Variability

    Change in heart rate variability measured continuously via the study application before and during the assigned intervention session.

    Measured: Baseline to immediately post-session

  2. Change in Systolic Blood Pressure

    Change in systolic blood pressure measured via automated cuff before and immediately after the assigned intervention session.

    Measured: Baseline to immediately post-session

  3. Change in Salivary pH

    Change in salivary pH measured via test strips before and immediately after the assigned intervention session.

    Measured: Baseline to immediately post-session

  4. Change in State-Trait Anxiety Inventory Score

    Change in self-reported state anxiety measured using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI), a 20-item scale ranging from 20 to 80, with higher scores indicating greater state anxiety, administered at baseline and immediately after the assigned intervention session.

    Measured: Baseline to immediately post-assessment

  5. Change in Perceived Stress Scale (PSS-10) Score

    Change in self-reported perceived stress measured using the 10-item Perceived Stress Scale (PSS-10), ranging from 0 to 40, with higher scores indicating greater perceived stress, administered at baseline and immediately after the assigned intervention session.

    Measured: Baseline to immediately post-assessment

  6. Recruitment Rate

    Percentage of eligible individuals screened who agree to enroll in the study.

    Measured: Up to 4 months

  7. Retention Rate

    Percentage of enrolled participants who complete their assigned study visit.

    Measured: Day 1

  8. Intervention Adherence

    Percentage of participants who complete the full 15-minute assigned intervention session (mindfulness meditation or story-listening control), as recorded by the study application

    Measured: Day 1

  9. Participant Acceptability

    Acceptability assessed via a 3-item investigator-developed measure: (1) enjoyment of the session, (2) comfort during the session, (3) perceived health benefit. Each item is rated on a 3-point scale (No / Neutral / Yes) and reported individually.

    Measured: Day 1

  10. Task Feasibility (Participant-Reported)

    Feasibility assessed via a 2-item investigator-developed measure: (1) physical ease of the seated/lying position, (2) clarity of the recorded audio instructions. Each item is rated on a 3-point scale and reported individually.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2026
  2. Study start14 Nov 2026 (estimated)
  3. Primary completion15 Mar 2027 (estimated)
  4. Study completion15 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07924904
Sponsor's protocol ID
STUDY00000925
Other IDs
CL034115600N230020280007408
Status last verified
Nov 2026
First submitted
8 Sep 2026
Last updated
9 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Data sharing plans have not yet been finalized. As a pilot study with a small sample size (n=60), the investigators will determine after study completion whether de-identified individual participant data will be made available, and if so, under what conditions (e.g., data use agreement, timeframe, and mechanism of access).

Questions about this trial

What is this clinical trial studying?

A study testing Guided Mindfulness Meditation and Neutral Story Listening in people with Test Anxiety and Stress, Psychological, run by University of South Carolina at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mina Karami, PhD Student (18032614523, karamim@email.sc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in MoCA Total Score (time frame: Immediately following the 15-minute intervention session (single study visit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in